SMTL ID : 1fm9.1

THE 2.1 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE HETERODIMER OF THE HUMAN RXRALPHA AND PPARGAMMA LIGAND BINDING DOMAINS RESPECTIVELY BOUND WITH 9-CIS RETINOIC ACID AND GI262570 AND CO-ACTIVATOR PEPTIDES.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

hetero-1-1-2-mer

Ligands

1 x 9CR: (9cis)-retinoic acid(Non-covalent)

9CR.1: 15 residues within 4Å: Chain A: I.44, A.47, A.48, Q.51, W.81, L.85, F.89, R.92, L.102, A.103, V.118, I.121, C.208, H.211, L.212 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:I.44, A:A.48, A:W.81, A:L.85, A:F.89, A:F.89, A:F.89, A:L.102, A:V.118, A:I.121, A:H.211 Hydrogen bonds: A:A.103 Salt bridges: A:R.92

1 x 570: 2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID(Non-covalent)

570.2: 22 residues within 4Å: Chain B: R.75, I.76, F.77, G.79, C.80, Q.81, S.84, H.118, I.121, Y.122, L.125, I.136, M.143, L.148, F.155, F.158, M.159, H.244, L.248, L.260, L.264, Y.268 18 PLIP interactions: 18 interactions with chain B Hydrophobic interactions: B:I.76, B:F.77, B:Q.81, B:I.121, B:L.148, B:F.155, B:F.158, B:L.260, B:L.264 Hydrogen bonds: B:S.84, B:Y.122, B:Y.122, B:H.244, B:Y.268 Salt bridges: B:H.118, B:H.244 pi-Stacking: B:F.77, B:F.158

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gampe Jr., R.T. et al., Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Mol.Cell (2000)

Release Date

2001-02-16

Peptides

RETINOIC ACID RECEPTOR RXR-ALPHA: A
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA: B
STEROID RECEPTOR COACTIVATOR: CD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
D

C
B

D
E

RETINOIC ACID RECEPTOR RXR-ALPHA

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA

STEROID RECEPTOR COACTIVATOR

Related Entries With Identical Sequence